CCL3 Polyclonal Antibody MBS9128219 from MyBioSource.com

Description

This locus represents a small inducible cytokine. The encoded protein, also known as macrophage inflammatory protein 1 alpha, plays a role in inflammatory responses through binding to the receptors CCR1, CCR4 and CCR5. Polymorphisms at this locus may be associated with both resistance and susceptibility to infection by human immunodeficiency virus type 1

Product Specs
ItemCCL3 Polyclonal Antibody
CompanyMyBioSource.com
Price $230.00Supplier Page View Company Product Page
Catalog NumberMBS9128219
Quantity0.05 ml
ApplicationsWestern Blot (WB)
Conjugate/TagUnconjugated
PurityAffinity Purification
ReactivityHuman, Mouse, Rat
TargetCCL3
IsotypeIgG
Molecular Weight10kDa
HostRabbit
NCBI Full Gene Namechemokine (C-C motif) ligand 3
NCBI Gene AliasesMIP-1-alpha, MIP1A, LD78ALPHA, G0S19-1, SCYA3
ClonalityPolyclonal

Add to Compare List

Questions and Answers

Can this antibody be used for studying inflammatory responses in human samples?

Yes, the CCL3 Polyclonal Antibody is known to play a role in inflammatory responses by binding to receptors such as CCR1, CCR4, and CCR5. Its reactivity with human samples makes it suitable for investigating the mechanisms of inflammation in human tissues.

What species can I use this antibody with in my experiments?

This antibody is reactive with mouse, human, and rat samples, allowing for versatile applications in various species for research purposes.

Is this antibody suitable for Western Blot applications?

Yes, the CCL3 Polyclonal Antibody is specifically indicated for use in Western Blot applications, making it a valuable tool for detecting the protein in various sample types.

What is the significance of the CCL3 protein in relation to HIV infection?

The CCL3 protein, also known as macrophage inflammatory protein 1 alpha, has been associated with polymorphisms that may influence both resistance and susceptibility to infection by human immunodeficiency virus type 1, highlighting its potential importance in HIV research.